Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.809 USD | +5.57% | -2.66% | -0.62% |
May. 09 | HOOKIPA Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 25 | Transcript : HOOKIPA Pharma Inc. - Special Call |
Financials (USD)
Sales 2024 * | 46.9M | Sales 2025 * | 14.93M | Capitalization | 75.83M |
---|---|---|---|---|---|
Net income 2024 * | -46M | Net income 2025 * | -102M | EV / Sales 2024 * | 1.62 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.08 x |
P/E ratio 2024 * |
-2.47
x | P/E ratio 2025 * |
-1.22
x | Employees | 165 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.47% |
Latest transcript on HOOKIPA Pharma Inc.
1 day | -0.22% | ||
1 week | -12.95% | ||
Current month | -13.64% | ||
1 month | -2.57% | ||
3 months | +19.92% | ||
6 months | +64.09% | ||
Current year | -5.40% |
Managers | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Klaus Orlinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Chairman | 63 | 17-09-30 | |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 0.805 | +5.05% | 201 601 |
24-05-13 | 0.7663 | -0.22% | 346,655 |
24-05-10 | 0.768 | -4.00% | 623,571 |
24-05-09 | 0.8 | 0.00% | 600,841 |
24-05-08 | 0.8 | -3.26% | 536,263 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.40% | 75.83M | |
+29.98% | 682B | |
+31.74% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.47% | 240B | |
+9.49% | 209B | |
-8.67% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- HOOK Stock